FILING ANALYSIS · TUESDAY, OCTOBER 27
Beta Bionics, Inc. BBNX — 8-K: Results of Operations and Financial Condition
neutral
Beta Bionics reported a 30% increase in net sales to $35.5 million and raised its full-year revenue guidance to $124-126 million, but also reported a net loss of $24.4 million and an adjusted EBITDA loss of $18.9 million. The company's cash position is strong with $373.6 million in cash, cash equivalents, and investments.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →